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The leaves of the Brazilian species Plinia cauliflora were used to obtain active hydroalcoholic extract 
and fractions enabling the development of efficient antiseptic pharmaceutical formulations. A chemical 
composition of 70% ethanol extract, aqueous and ethyl acetate fractions was analyzed by thin-layer 
chromatography and for phenol content. Antimicrobial activity was tested against Staphylococcus aureus, 
Staphylococcus epidermidis, Escherichia coli, Lactobacillus acidophilus and Candida albicans by the 
agar diffusion method and the minimum inhibitory concentration was assayed by broth microdilution. 
Extract microbiological quality was tested to avoid contamination in the formulations. A mouthwash 
and a topical cream containing the extract were developed and antiseptic activity was assessed by agar 
diffusion. Sensory and physicochemical stability of the formulations were assayed. Chromatography 
indicated the presence of terpenes, flavonoids and tannins in the extract and fractions and total phenol 
content were found to be high. The plant samples were active against all the microorganisms tested, 
except for Lactobacillus acidophilus. Both topical formulations showed antiseptic activity and stability. 
Thus, these may be used as antimicrobials in skin infections, but would be more useful in the treatment 
of candidiasis.
Uniterms: Antiseptic formulations/design. Plinia cauliflora/antimicrobial activity. Plinia cauliflora/
antiseptic activity. Mouthwash. Plant extract. Topical cream.
As folhas da espécie brasileira Plinia cauliflora foram utilizadas a fim de se obter um extrato hidroalcoólico 
e frações ativas proporcionando o desenvolvimento de eficazes formulações farmacêuticas antissépticas. 
A composição química do extrato etanólico 70%, fração aquosa e acetato de etila foi analisada por 
cromatografia em camada delgada e teor de fenóis.  A atividade antimicrobiana foi testada frente a 
Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Lactobacillus acidophilus 
e Candida albicans por difusão em ágar e a concentração inibitória mínima foi determinada por 
microdiluição. A qualidade microbiológica do extrato foi avaliada para evitar a contaminação das 
formulações. Foram desenvolvidos um enxaguatório bucal e um creme tópico contendo o extrato sendo 
que a atividade antisséptica foi ensaiada por difusão em ágar. A estabilidade sensorial e físico-química 
foram testadas. A cromatografia indicou a presença de terpenos, flavonóides e taninos no extrato e 
frações, observando-se alto teor de fenóis totais. As amostras vegetais foram ativas contra todos os micro-
organismos testados, exceto Lactobacillus acidophilus. Ambas as formulações apresentaram atividade 
antisséptica e estabilidade. Desta forma, infere-se que as formulações desenvolvidas podem ser utilizadas 
como antissépticas em infecções de pele, podendo ser mais eficazes no tratamento de candidíase.
Unitermos: Formulações antissépticas/planejamento. Plinia cauliflora/atividade antimicrobiana. Plinia 
cauliflora/atividade antisséptica. Enxaguatório bucal. Extrato vegetal. Creme tópico.
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INTRODUCTION
Antimicrobial agents have been used since the se-
venteenth century for the treatment of infectious diseases. 
Over the past 20 years, there has been a growing interest 
in screening natural products as a potential source of new 
antimicrobial substances (Silva et al., 2005; Suffredini et 
al., 2006). The antimicrobial properties of many substan-
ces extracted from plants have been scientifically proven. 
Thus, research conducted in several countries, including 
Brazil, where the plant diversity is exceptional, has shown 
a variety of substances to be effective in controlling the 
growth of microorganisms, as reported in the work of Pes-
sini et al. (2003), Souza et al. (2003), Fiuza et al. (2008) 
and many others.
Plinia cauliflora (Mart.) Kausel is a tree of the 
Myrtaceae family, widely distributed in Brazil, where its 
popular edible fruit is known as jaboticaba and the bark is 
used as a source of astringent (Lorenzi, 2000). This tree 
occurs in alluvial plains and open rain forests, being found 
in forests in Brazil, Argentina and Paraguay. P. cauliflora 
produces abundant delicious fruits two or more times 
a year (Barros et al., 1996; Lorenzi, 2000). The bark is 
astringent and used by Brazilians to treat diarrhoea and 
skin irritations (Lorenzi, 2000). Extracts of the leaves were 
shown to have antimicrobial activity in previous work 
(Souza-Moreira et al., 2010). These promising results 
prompted this study to assess the antimicrobial activity 
of extracts and fractions from leaves of Plinia cauliflora 
against several species of microorganisms and to develop 
a topical cream for skin and genital administration as well 
as a mouthwash containing the extract, which should be 
effective, stable and of good quality.
Some mouthwashes are responsible for reducing 
the microbial load in the oral cavity (Shapiro et al., 2002). 
Bacterial and fungal infections are prevalent in critically 
ill and immunocompromised patients, and there is a high 
prevalence of oral candidiasis in immunocompromised 
patients and patients with dentures (Abu-Elteen and Abu-
Alteen, 1998; Webb et al., 1998), especially when denture 
hygiene is poor (Webb et al., 2005). Alcohol and chlorhe-
xidine are frequently used as oral cavity antimicrobials but 
show significant irritant potential. Sensitive and inflamed 
mucosa, especially that of cancer, is more susceptible to 
the unpleasant taste and irritant property of these products 
(Bahna et al., 2007). 
Creams are well tolerated formulations because 
they interact mildly with the skin (Xhauflaire-Uhoda et 
al., 2008). They provide a barrier effect and improve per-
meation of active compounds into the human epidermis. 
Several topical formulations were prepared with Melaleu-
ca alternifolia essential oil, a potent antimicrobial agent, 
at concentrations up to 5% (Biju et al., 2005; Reichling 
et al., 2006). Emulsion, ointment and cream proved to 
enhance essential oil permeation through the skin where 
this is important in the treatment of some subcutaneous 
infections such as candidiasis (Reichling et al., 2006).
The purpose of the present study was to develop, 
for the first time, two antiseptic phytopharmaceutical 
formulations with extract of the Brazilian native leaves of 
P. cauliflora to help control infections in oral and vaginal 
mucous membranes.
MATERIAL AND METHODS 
Media, chemicals and reagents
Brain-Heart Infusion broth, Sabouraud broth, 
Sabouraud Dextrose agar and microbiological quality 
control media besides agar were acquired from Acume-
dia (Lansing, Michigan, USA); MRS broth was acquired 
from Fluka (Steinheim, Switzerland); Müeller Hinton 
agar was acquired from Himedia (Mumbai, India) and 
RPMI-1640 broth was acquired from Sigma (St. Louis, 
Missouri, USA). Solvents (glycerol, ethanol, ethyl acetate, 
chloroform, methanol, n-propanol, dimethyl sulfoxide, 
propylene glycol, sorbitol), glucose, sodium saccharine 
and p-anysaldehide-sulphuric acid were purchased from 
Labsynth (Diadema, São Paulo, Brazil). Emulsifying wax 
and methylparaben were obtained from Volp (Osasco, São 
Paulo, Brazil); grape seed oil and propylparaben were 
obtained from Deg (São Paulo, São Paulo, Brazil); octyl 
stearate and carbomer were acquired from PharmaSpecial 
(Santana de Parnaíba, São Paulo, Brazil); and butylhydro-
xy toluene was acquired from Makeni Chemicals (Dia-
dema, São Paulo, Brazil). The Folin-Ciocalteau reagents 
were obtained from Imbralab (Ribeirão Preto, São Paulo, 
Brazil); tannic acid was acquired from Ecibra (Santo 
Amaro, São Paulo, Brazil); sodium carbonate, resazurin 
and  2,3,5-triphenyltetrazolium were obtained from Vetec 
(Duque de Caxias, Rio de Janeiro, Brazil).
Microorganisms
The following reference strains were used in the 
study: Staphylococcus aureus ATCC 25923, Staphylo-
coccus epidermidis ATCC 12228, Escherichia coli ATCC 
10536, Lactobacillus acidophilus INCQS 00076 and 
Candida albicans ATCC 64548. Bacteria were maintained 
in Brain-Heart Infusion (BHI) broth and L. acidophilus in 
MRS broth, both containing 20% (v/v) glycerol at -20 °C. 
Before testing, the bacteria were transferred to fresh BHI 
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medium and left to grow aerobically for 24 h at 37 °C. 
The inocula for the tests were prepared by diluting the-
se bacterial suspensions in saline to the turbidity of the 
0.5 McFarland standard (108 CFU mL-1) (CLSI, 2003a), 
except in the case of L. acidophilus, which was diluted to 
match the 5 McFarland standard (109 CFU mL-1) (Ocaña 
et al., 2006). C. albicans was maintained by culturing on 
Sabouraud Dextrose Agar (SDA) and, for the tests, trans-
ferred to Sabouraud broth and grown at 35 °C for 48 h. The 
inoculum was prepared by adjusting the suspension turbi-
dity to match the 0.5 McFarland standard (106 CFU mL-1), 
in saline (CLSI, 2009).
Plant material
Leaves of Plinia cauliflora were collected in São Car-
los city, state of São Paulo (22º01’16.6” N, 47°53’57.0” W). 
Specimens of this species were identified by Marcos So-
bral and a copy was deposited in the herbarium of Escola 
Superior de Agricultura “Luiz de Queiroz” (ESALQ), USP 
at Piracicaba (São Paulo, Brazil) (ESA No. 96038).
Preparation of leaf extract and fractions
The leaves were dried for four days at 40 °C, pow-
dered in a knife mill and stored. The dried and powdered 
leaves of P. cauliflora were extracted to exhaustion with 
70% ethanol (v/v) in a percolating apparatus at room tem-
perature (Farmacopéia Brasileira, 1988). The extract was 
dried under reduced pressure at 40 °C and weighed. This 
extract was subjected to liquid-liquid partition with water 
and ethyl acetate. The fractions were dried under reduced 
pressure at 40 °C and weighed.
Pharmacognostic analysis
Thin-layer chromatography: Preliminary phar-
macognostic analysis was performed by comparative 
thin-layer chromatography (TLC), applying the 70% 
ethanol extract and fractions to a silica gel 60 F254 pla-
te. The mobile phase consisted of the organic phase of 
chloroform:methanol:n-propanol:water (5:6:1:4, v/v). The 
spots were observed under UV and visible light and after 
being sprayed with p-anisaldehyde-sulfuric acid reagent.
Phenolics content: Total phenolic compounds in the 
extract were determined by the Folin-Ciocalteau method 
(1927), adapted by Monteiro et al. (2006). Results were 
expressed in terms of a standard curve for tannic acid. 
To prepare this, several aliquots of a  1.0 mg mL-1 tannic 
acid aqueous solution were diluted in 7.5 mL of distilled 
water, 0.5 mL 10% Folin-Ciocalteau reagent and 1.0 mL 
0.75% Na2CO3 were added and the volume completed to 
10 mL with water. Extract was treated similarly, but to a 
final concentration of 10 µg mL-1. After 3 h, the absorban-
ce was measured at 760 nm with a Shimadzu UV-1603 
spectrophotometer. 
Microbiological quality control of the extract
In order to avoid further contamination in the formu-
lations the extract microbiological assay was performed. 
The numbers of viable aerobic microorganisms (Salmo-
nella sp, Escherichia coli, Pseudomonas aeruginosa and 
Staphylococcus aureus) in the extract were determined 
by methods recommended by the Farmacopeia Brasileira 
(1988) and Pinto et al. (2003), performed in triplicate.
Agar diffusion method
Bacteria: Except for lactobacilli, the test was perfor-
med in Müller Hinton agar (MHA) following the Guide-
line M2-A8 from the Clinical and Laboratory Standards 
Institute (CLSI, 2003a). Plates were seeded separately, 
with each bacterial cell suspension at 1% (v/v), giving 
106 CFU mL-1. L. acidophilus was inoculated at 1% (v/v) 
(107 CFU mL-1) in MRS agar (Ocaña et al., 2006). 
Yeast: The test was performed in MHA supplemen-
ted with 0.05 mg mL-1 methylene blue and 2% glucose, 
inoculated with 1% of the cell suspension (104 CFU mL-1) 
as in Guideline M44-A2 from the CLSI (2009). In all tests, 
a steel template was placed on the seeded agar and sepa-
rately, in each 6 mm, 100 µL of the extract, ethyl acetate 
fraction or aqueous fraction was added at a concentration 
of 50 mg mL-1, in dimethyl sulfoxide (DMSO) diluted in 
saline (1:5, v/v, or 100 µL of the positive control: ampi-
cillin (50 µg mL-1) for all bacteria and amphotericin B 
(64 µg mL-1) for yeast. A negative solvent control, 
DMSO:BHI (1:5, v/v), was also used on all plates. The 
tests were performed in triplicate.
Broth microdilution method
Minimum inhibitory concentrations (MIC) were 
determined as recommended in Guidelines M7-A6 of the 
Clinical and Laboratory Standards Institute (CLSI, 2003b) 
for bacteria and M27-A2 for yeast (CLSI, 2002). The test 
was performed in sterile 96-well microplates. The test solu-
tions of extract and fractions in DMSO:medium (1:10 v/v) 
were transferred to microplate wells so as to obtain two-
fold serial dilutions in a concentration range from 2.5 to 
0.039 mg mL-1, with diluted ampicillin from 12.5 to 
0.019 µg mL-1 and amphotericin B from 16 to 0.01 µg mL-1, 
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as positive controls. The inocula (100 µL), containing 
2.5x105 CFU mL-1 of bacteria or 2.5x103 CFU mL-1 of ye-
ast (in BHI or RPMI-1640 broth),were added to each well. 
A number of wells were reserved in each plate to check 
sterility (without inoculum), inoculum viability (without 
extract) and DMSO inhibitory effect. Plates were incubated 
aerobically with shaking (100 rotates per min) at 35 °C, 
for 24 h for bacteria and 48 h for yeast. After incubation, 
microbial growth was observed by the addition of a 0.5% 
aqueous solution of resazurin for bacteria and 1% aqueous 
solution of 2,3,5-triphenyltetrazolium for yeast. MIC was 
defined as the lowest concentration that inhibited growth 
(Gabrielson et al., 2002; Duarte et al., 2005). The minimum 
bactericidal and fungicidal concentrations (MBC and MFC) 
were determined by subculturing from microplate wells on 
MHA and Sabouraud agar plates, respectively, which were 
incubated for 24 h at 37 °C for bacteria and 48 h at 35 °C 
for yeast. MBC and MFC were the lowest concentrations 
without viable cells. The tests were performed in triplicate.
Formulation preparation
In the topical cream (O/W) formula, the following 
materials were used: emulsifying wax (1.5%), octyl 
stearate (2.0%), grape seed oil (2.0%), methylparaben 
(0.002%), propylparaben (0.018%), butylhydroxy tolue-
ne (0.02%), propylene glycol (4.0%), carbomer (30%), 
extract of P. cauliflora (0.25%) and aqua q.s. 100% by 
weight. The extract was incorporated in the cream at 40 °C 
and homogenized. The mouthwash was prepared from the 
following materials: sorbitol (3.0-5.0%), methylparaben 
(0.20%), sodium saccharin (q.s.), extract of P. cauliflora 
(0.25%) and aqua q.s. 100%. Extract of Plinia cauliflora 
was dissolved in sorbitol and incorporated into the prepa-
red solution of mouthwash. The concentration of extract 
used in these preparations was determined from the MIC 
values. The cream and mouthwash were also prepared 
without the extract, for comparison with the activity of 
antiseptic preparations containing extract.
Determination of antimicrobial activity of 
pharmaceutical formulations
The antiseptic activity of preparations was tested by 
the agar diffusion method. The density of microorganisms 
and preparation of the plates were as in the test for antimi-
crobial activity described above. The mouthwash samples 
(200 µL) were placed in steel templates on the solidified 
inoculated agar (Ocaña et al., 2006), but the samples of 
topical cream were added by the pour-plate method in the 
culture medium. Tests were performed on the mouthwash 
with and without extract and the topical cream with and 
without extract. The positive controls were ampicillin 
(50 µg mL-1) for bacteria and amphotericin B (64 µg mL-1) 
for yeast. The plates were incubated for 24 h at 37 °C for 
bacteria and 48 h at 35 °C for yeast. All tests were perfor-
med in triplicate and the mean diameters of the inhibition 
zones were recorded.
Physical stability tests
Physical stability was tested by subjecting the for-
mulations to storage at 5 ± 2 °C, at 45 ± 2 °C and expo-
sed to light at room temperature, with a control at room 
temperature (27 ± 2 ºC). Samples from each formulation 
container were tested at the start and after 1, 7, 15, 30, 60 
and 90 d, by the following methods (Isaac et al., 2008; 
Ordoñez et al., 2009):
Centrifugation assays: Five grams of each sample was 
centrifuged three times at 3000 rpm for 30 min each time. 
Subsequently, preparations were placed in opaque contai-
ners and stored under the stress conditions described above.
pH measurements: One gram of each formulation 
was weighed and diluted to 10 mL with distilled water. The 
mixture was homogenized and its pH measured with a pH 
meter. All measurements were made at room temperature 
in triplicate for each analyzed sample.
Sensory properties: Color, odor and appearance 
were monitored at the same time intervals as the other 
parameters.
Viscosity: Minimum apparent viscosity was de-
termined with a cone and plate Haake rheometer (Rhe-
ostress1), equipped with a recirculating water-bath, to 
control the sample container temperature, and Rhcowin-3 
software. Viscosity was measured at progressively higher 
shear rates (speed of rotation 0-100 s-1) for the upward 
curve and the procedure was repeated in reverse, with 
progressively slower rates (100-0 s-1) for the descending 
curve, both for 120 s. All tests were performed in triplicate 
for each sample analyzed.
Statistical analysis
The results are expressed as mean ± SD. MIC, MBC 
and MFC are expressed as mode values. Statistical signi-
ficance was tested using Student’s t test. A difference was 
taken to be significant at P < 0.05.
RESULTS
The present study was conducted to investigate 
the antimicrobial activity of P. cauliflora leaf extract and 
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fractions and to use this extract to prepare pharmaceutical 
formulations with antimicrobial properties. The extract 
was chosen for its good activity (Souza-Moreira et al., 
2010) and with the aim of providing cheaper formulations. 
The dried 70% ethanol extract and its aqueous and 
ethyl acetate fractions yielded 24 g, 1.65 g and 4.22 g, 
respectively. The TLC indicated the presence of terpenes, 
flavonoids and tannins in the hydroethanolic extract, as 
described in the work of Souza Moreira et al. (2010). 
Tannins were mainly found in the aqueous fraction and 
terpenes and flavonoids in the ethyl acetate. The extract 
showed 70% phenolic content.
The microbiological quality control showed that the-
re was no growth of the four pathogenic microorganisms, 
Salmonella, E. coli, S. aureus and P. aeruginosa, in the 
leaf extract. The total viable count of microorganisms was 
17 CFU g-1 of extract, which allows its approval, according 
to the official limit of not more than 5x103 CFU g-1 or mL 
for non-sterile products (Farmacopeia Brasileira, 1988). 
In the agar diffusion tests, the aqueous fraction 
and whole extract were the samples that showed the best 
antimicrobial activity against the bacterium S. aureus 
and the yeast Candida albicans, while the acetate frac-
tion showed the smallest inhibition zones (Table I). No 
samples showed inhibitory activity against Lactobacillus 
acidophilus. Table I also shows the values of MIC, MBC 
and MFC for the extract and fractions. It can be seen 
that the yeast was more sensitive, with smaller MICs, 
TABLE I – Antimicrobial activity of extract and fractions from leaves of P. cauliflora
Microorganism S. aureus S. epidermidis E.coli L. acidophilus C. albicans
Sample Zone* MIC† MBC† Zone MIC MBC Zone MIC MBC Zone MIC MBC Zone MIC MFC†
Extract
12.36± 
2.38
1250 >2500
11.97± 
3.46
2500 2500
11.45± 
1.63
2500 2500 0 NA‡ NA
15.36± 
3.40
156 >2500
Aqueous 
fraction
18.62± 
3.80
1250 2500
11.14± 
1.32
1250 >2500
13.25± 
2.56
2500 2500 0 NA NA
15.91± 
3.78
78 >2500
Ethyl acetate 
fraction
13.85± 
2.08
1250 >2500
10.58± 
0.40
1250 1250
13.11± 
0.70
2500 2500 0 NA NA
12.05± 
3.24
312 >2500
Antimicrobial
19.53± 
0.09
0.39 0.39
13.98± 
3.58
1.56 1.56
19.87± 
2.38
0.78 0.78
24.14± 
10.23
NA NA
13.70± 
4.55
0.25 0.25
* inhibition zone (mm) ± standard deviation.
† MIC, MBC and MFC values in mg mL-1.
‡ NA: not applicable.
although the minimum fungicidal concentrations were 
higher. The negative control using only DMSO did not 
inhibit the microbial growth.
The preparations were formulated with crude extract 
as antiseptic agent, not as preservative agent. Though not 
the best inhibition zones, the extract showed considerable 
antiseptic activity and was chosen since this material was 
much cheaper than the fractions. The topical cream and 
mouthwash containing the extract proved to be effective 
antiseptics in the agar diffusion tests, against all four mi-
croorganisms tested, as shown in Table II. Control prepara-
tions without extract did not show growth inhibition zone 
so they are not shown in Table II. A product is classed as 
an antiseptic when it produces an inhibition zone of 8 mm 
or more (using steel templates with 6 mm diameter wells) 
(Roessler, 1983).
Preparations showed no phase separation when 
centrifuged repeatedly and their sensory parameters of 
appearance, color and odor did not change throughout 
the period of exposure to stress conditions. Moreover, no 
significant changes in physical and chemical properties 
were observed, attesting to the stability of the prepara-
tions of topical cream and mouthwash with the extract of 
P. cauliflora.
The initial pH of the mouthwash and the topical 
cream was 6.50. These values did not vary by more than 
0.5 during the period under stress conditions so that the 
pH remained compatible with mucosal and cutaneous pH 
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and the formulations could be considered stable (Isaac et 
al., 2008).
The results of the viscosity tests can be seen in Figu-
re 1 for the mouthwash (A) and for the topical cream (B).
It was observed that the viscosity of the emulsion 
(Figure 1 (B)) decreased slightly from initial value when 
subjected to stress conditions, but the overall variation was 
less than 10% and the emulsion is thus considered stable, 
according to Isaac et al. (2008). No significant change 
was observed in the viscosity of mouthwash (Figure 1 
(A)). Its value was close to zero, as the main constituent 
of the formulation was water, which has this viscosity 
profile (Schramm, 2006). Since viscosity is a physicoche-
mical parameter that reveals the flow properties of a fluid 
(Schramm, 2006), it was concluded that both preparations 
were stable with respect to this property.
DISCUSSION
In an early comparative study of the antioxidant 
and antimicrobial activities of 50% ethanol, 70% ethanol, 
acetone:water (7:3, v/v) and chloroform extracts obtained 
from the leaves of P. cauliflora by percolation, the best 
results were shown by the non-apolar extracts (Souza-
Moreira et al., 2010). Some phytochemical characteriza-
tion and biological activity were described previously by 
Souza-Moreira et al. (2010) while the present study has 
reproduced the standardized obtention of the 70% extract 
and provided pharmaceutical formulations confirming the 
activity of the extract in topical products. 
Chemical compositions of the extract and fractions 
were confirmed by TLC and quantitative analysis. Choi 
et al. (2006) suggested that many biological activities in 
plants are due to the content of total phenols, such as fla-
vonoids and tannins. The quantitative analysis of phenolic 
compounds demonstrated that the 70% ethanol extract of 
P. cauliflora standardized as 70% phenolic compounds 
may be sufficient to produce an inhibitory effect on the 
growth of pathogenic bacteria and yeasts. 
The extract showed no growth of the specific pa-
thogenic microorganisms and a low total viable count of 
microorganisms, ensuring that the microbial load in the 
final product does not lower its quality or endanger the 
patient (Pinto et al., 2003).
Serafin et al. (2007), working with Plinia glomerata 
leaves, found MIC values for the aqueous and ethyl acetate 
fractions ranging from 500 to 1000 µg mL-1 against E. coli 
and S. aureus, whereas against C. albicans the aqueous 
fraction had a MIC of 250 µg mL-1, showing that this yeast 
was more susceptible than the bacteria, as in the present 
study of the leaf extract of P. cauliflora, belonging to the 
same genus.
An important issue to be considered in relation to 
the fight against infection is the maintenance of the normal 
bacterial population in people, such as Lactobacillus spp 
bacteria in the human vaginal mucosa, which can protect 
against pathogens (Sobel, 2000; Reid, 2003; Andreu, 
2004) by producing acids, hydrogen peroxide, bacteriocins 
and biosurfactants (Hillier et al., 1992). Since in this study 
the yeast C. albicans showed a greater susceptibility to 
the extract, it was especially interesting to note that the 
exemplary vaginal microorganism, L. acidophilus, was 
not sensitive to the plant extract, which may justify the 
development of pharmaceutical formulations containing 
TABLE II – Growth inhibition zones of antiseptic preparations 
developed
Microorganisms
Topical 
cream
Mouthwash
Antimicrobial 
control
S. aureus 21.45 ± 1.88* 15.27 ± 0.87 22.32 ± 2.52
S. epidermidis 18.27 ± 0.75 16.61 ± 5.23 22.38 ± 1.64
E.coli 22.78 ± 1.32 15.26 ± 0.48 22.91 ± 2.96
C. albicans 20.81 ± 2.40 20.55 ± 4.80 20.74 ± 1.49
* Mean inhibition zone diameters (mm) ± standard deviations
FIGURE 1 – Viscosity of the mouthwash (A) and of the topical cream (B) containing extract, subjected to stress conditions over 
90 days.
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extract or fractions of leaves of P. cauliflora to assist in the 
treatment of candidiasis by acting on the pathogen without 
disturbing the balance of the mucosal microbiota. Also, it 
was observed that the formulations provided antisepsis 
against the microorganisms tested, especially against 
the yeast. Candida albicans is a common commensal 
microorganism in skin and the genital area, but becomes 
pathogenic under predisposing conditions. To treat skin 
and the genital area it was important to develop a viscous 
topical cream with the active extract (Calderone, 2002). 
Another interesting finding of the present work is that, 
while M. alternifolia essential oil is used in creams at 5% 
(Biju et al., 2005; Reichling et al., 2006), the present study 
showed an efficient antiseptic formulation using 0.25% of 
a vegetal sample.
Cordeiro et al. (2006) observed that mouthwashes 
containing the plant species Rosmarinus officinalis, Plan-
tago major, Tabebuia impetiginosa, Achillea millefolium 
and Nasturtium officinale also showed some activity, but 
there was no difference between the results produced by 
the mouthwashes with or without the plant extracts at 2% 
or 4%, while in our study a clear difference can be seen 
between the mouthwash containing the extract at 0.25% 
and the control.
Besides effectiveness, it is necessary to assess the 
stability of a formulation. The stability study provides 
information on the performance of the product after any 
given time intervals, taking into account the environmental 
conditions to which it may be subjected from production to 
expiry date (Isaac et al., 2008). In the accelerated stability 
test, it was observed that the formulations did not change 
significantly when subjected to stress conditions. Thus, 
these preparations show promise for the treatment of in-
fections, especially candidiasis, since they possess activity 
against several pathogens, but none against the lactobacilli 
present in the normal mucosal microbiota, and are within 
the reference limits of quality and stability.
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